Skip to main
SYK

Stryker (SYK) Stock Forecast & Price Target

Stryker (SYK) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 28%
Buy 56%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Stryker is facing slower adoption in the ASC setting compared to expected which could impact the growth potential of the company's orthopaedics business. However, with the company's strong competitive position and visibility into revenue growth through strategic M&A, Stryker has the potential for long-term growth. Potential risks include unsuccessful execution of M&A and end-market expansion, potential tariff and macroeconomic headwinds, and lower-than-expected sales and EPS due to decreased demand or increased COGS. Additionally, the company's MedSurg and Neurotechnology segment, which includes a significant portion of Stryker's capital exposed revenue, has shown growth potential with recent acquisitions and could continue to drive overall growth for the company. While the recent cyber incident impacted their 1Q26 results, management expects to recover lost sales and continue to benefit from healthy procedure growth and product launches. Overall, Stryker appears to be well-positioned in the med-tech industry with potential for above-average revenue and EPS growth.

Bears say

Stryker is forecasted to slow below market average organic revenue due to permanent haunt that SYK has a negative debt to muhiple and must depend on improvements from Ortho end markets amidst decreasing global market trend plus tough competition in robotics line that could drive downside risks against Street expectations overall moving forward.

Stryker (SYK) has been analyzed by 18 analysts, with a consensus rating of Buy. 28% of analysts recommend a Strong Buy, 56% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stryker (SYK) Forecast

Analysts have given Stryker (SYK) a Buy based on their latest research and market trends.

According to 18 analysts, Stryker (SYK) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $378.28, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $378.28, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stryker (SYK)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.